FDA Recalls Oliver's Harvest CBD+Lidocaine Cream for Manufacturing Violations
Pharma-Natural Inc. is recalling Oliver's Harvest CBD+Lidocaine HCL 4% Pain Relief Cream due to current good manufacturing practice violations, including lack of process and cleaning validation.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP violations (lack of validation and stability studies) without reported illnesses or injuries, fitting the 'voluntary precautionary recalls' or 'low-risk contamination' criteria for a Moderate severity score.
Plain-English summary
Pharma-Natural Inc. is recalling 1,000 bottles of Oliver's Harvest CBD+Lidocaine HCL 4% Pain Relief (Lidocaine HCL 4%) Topical Analgesic Cream, 4 OZ (113.4 g) bottle with pump. The product is distributed by Coast to Coast Natural, Inc., in Wellington, FL, and carries NDC 63766-119-04. The recall covers all lots remaining within their expiration dates.
The recall was initiated because the products were manufactured with current good manufacturing practice (CGMP) violations. Specifically, the source text notes a lack of process validation, cleaning validation, and stability studies. The FDA has classified this recall as Class II.
The product was distributed to consignees in Florida and Texas, who may have further distributed it nationwide in the USA and Puerto Rico. Consumers should stop using the product and contact the distributor or manufacturer for instructions on return or disposal.
The recalled product
- Product
- Oliver's Harvest CBD+Lidocaine HCL 4% Pain Relief (Lidocaine HCL 4%) Topical Analgesic Cream, 4 OZ (113.4 g) bottle with pump, Distributed by: Coast to Coast Natural, Inc., Wellington, FL 33414, NDC 63766-119-04.
- Manufacturer
- Pharma-Natural Inc.
- Category
- Drug — Topical Analgesic
- Affected units
- 1,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Part of a larger recall action
This product is one of 16 recalled by Pharma-Natural Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pharma-Natural Inc.
See all →- ModeratePharma Natural Biotin 5000 mcg Dietary Supplement Recalled for Sub-Potency
FDA (Food) · 2023-10-04
- ModeratePharma-Natural Recalls LidoAID Gel Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls AbeeMed Cream Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls SORBUGEN Cough Syrup Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModerateLido E.R. Lidocaine Cream Recalled for Manufacturing Violations
FDA (Drugs) · 2019-07-31
Same hazard · cgmp violation
See all →- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateNeuroquell products recalled over current good manufacturing practice violations
FDA (Drugs) · 2025-09-17
- ModerateOptim V Anti-Itch Cream Recalled for Current Good Manufacturing Practice Deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
Similar recalls
- SevereSoothing Sore Relief Lidocaine Cream Recalled for High Potency
FDA (Drugs) · 2019-09-25
- SevereFDA Recalls Soothing Sore Relief Lidocaine Gel Due to Contamination
FDA (Drugs) · 2019-09-25
- ModerateRidge Properties Recalls Bed Sore Cream Due to Manufacturing Control Issues
FDA (Drugs) · 2017-11-29
- ModerateLidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- SevereSuperior Pain & Itch Relief Cream Recalled for Lidocaine Contamination
FDA (Drugs) · 2019-09-25
- SevereSuperior Pain & Itch Relief Lidocaine Gel Recalled for Contamination
FDA (Drugs) · 2019-09-25